As ALS progresses, annual healthcare costs for U.S. patients increase from an average of $31,000 to over $120,000, a Biogen ...

HEALEY ALS, a platform trial testing multiple potential treatments for amyotrophic lateral sclerosis, is amending its master ...

The HEALEY ALS platform trial, which is simultaneously testing multiple potential treatments for amyotrophic lateral sclerosis (ALS), is amending its master protocol to allow a longer follow-up time ...